Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Zomedica’s Knowns, Known Unknowns, and its Unknown Unknowns

By Dana Blankenhorn, InvestorPlace Contributor

Truforma uses acoustic radio waves to analyze the chemical composition of small samples, and can diagnose some common diseases of dogs and cats.

SRNGU Stock: Betting the Sponsors Is True SPAC Speculation

By Dana Blankenhorn, InvestorPlace Contributor

Eagle Acquisition is looking for its seventh deal with SRNGU stock. The team behind it previously took DraftKings and Skillz public.

7 Ways to Define a Blue-Chip

By Dana Blankenhorn, InvestorPlace Contributor

The ranks of blue-chip stocks are constantly changing, and what you call a blue-chip investment will also change as you age.

VG Acquisition Stock: The Value’s in the DNA Vault, Not the Spit Kits

By Dana Blankenhorn, InvestorPlace Contributor

If 23andme is worth $3.5 billion, it's based on the long-term asset of its DNA database, not the cash it gets from consumers for its saliva testing kits.

BowX: Run, Don’t Walk, From the WeWork IPO

By Dana Blankenhorn, InvestorPlace Contributor

WeWork lost $3.2 billion last year and now calls itself a technology platform for creating flexible workspaces.

Load More